ABSI Historical PE Ratio Notes

— Absci Corporation (ticker: ABSI) is a biotechnology company focused on harnessing artificial intelligence (AI) & synthetic biology to discover, design, & develop novel protein-based therapeutics. Through its proprietary platform, Absci partners with major pharmaceutical & biotechnology companies to accelerate drug discovery, especially targeting complex biologics that are hard to create using traditional methods. As you review historical price, earnings, & price-to-earnings (PE) ratio data, it's important to understand that Absci has historically been a pre-revenue or early-revenue company, investing heavily in R&D & innovation rather than generating stable earnings. This means that its PE ratio may often be extremely high, volatile, or even undefined (when earnings are negative), reflecting the market's speculative outlook on its future growth potential rather than current profitability. In biotech & AI-driven drug development, significant milestones—such as successful partnerships or technological breakthroughs—can create sharp movements in market price relative to earnings, further impacting historical PE ratios. As you analyze ABSI's PE trends, keep in mind that these numbers are influenced less by traditional profit metrics & more by investor expectations about Absci’s ability to revolutionize biopharmaceutical development & eventually turn innovation into sustainable profits.

On this page we presented the ABSI Historical PE Ratio information for Absci' stock. The average ABSI historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ABSI historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ABSI historical PE result, against the recent PE: when this page was posted on 8/11/2026, the most recent closing price for ABSI had been 9.41, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ABSI or any other given stock, valuation analysis for ABSI can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Absci PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ABSI. Thanks for visiting, and the next time you need to research ABSI Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.